Humanetics Corporation announced today that executive management team members will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference this week.
The conference takes place on Thursday, May 29th, and Humanetics will be featured during the 1:30 – 2:10 ET time slot.
About Humanetics Corporation
Humanetics is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs, with a focus on radiation modulators for oncology and medical countermeasures. For more information, visit www.humaneticscorp.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527564713/en/
Humanetics to participate in benchmark investor conferrence.
Contacts
Ronald J. Zenk
Chief Executive Officer
Humanetics Corporation
952-400-0400